TickerFacts.

Lite Strategy, Inc. (LITS): Net Income

Annual figures by period end, from SEC filings.

-$15.95M
Year ended 2025-06-30
-$60.82M
Trailing 12 months to 2026-03-31
$17.78M2002-06-30: -$123.0K2003-06-30: -$3.03M2004-06-30: -$8.54M2005-06-30: -$6.42M2006-06-30: -$7.39M2007-06-30: -$13.82M2008-06-30: -$12.41M2009-06-30: -$11.18M2010-06-30: -$7.90M2011-06-30: -$6.78M2012-06-30: -$7.52M2013-06-30: -$11.19M2014-06-30: -$27.15M2015-06-30: -$32.69M2016-06-30: -$20.86M2017-06-30: $2.67M2018-06-30: -$40.07M2019-06-30: -$16.82M2020-06-30: -$47.17M2021-06-30: -$41.00M2022-06-30: -$54.00M2023-06-30: -$32.00M2024-06-30: $17.78M2025-06-30: -$15.95M-$15.95M
2002-06-30 Net Income (USD) 2025-06-30
Period endedNet IncomeChange YoYSource filing
2025-06-30-$15.95Mn/m2025-09-26, From 2024-07-01
2024-06-30$17.78Mn/m2025-09-26, From 2023-07-01
2023-06-30-$32.00Mn/m2025-09-26, From 2022-07-01
2022-06-30-$54.00Mn/m2023-10-27, From 2021-07-01
2021-06-30-$41.00Mn/m2023-10-27, From 2020-07-01
2020-06-30-$47.17Mn/m2022-09-08, From 2019-07-01
2019-06-30-$16.82Mn/m2022-05-23, From 2018-07-01
2018-06-30-$40.07Mn/m2020-09-09, From 2017-07-01
2017-06-30$2.67Mn/m2019-08-28, From 2016-07-01
2016-06-30-$20.86Mn/m2018-08-30, From 2015-07-01
2015-06-30-$32.69Mn/m2017-09-05, From 2014-07-01
2014-06-30-$27.15Mn/m2016-09-06, From 2013-07-01
2013-06-30-$11.19Mn/m2015-09-02, From 2012-07-01
2012-06-30-$7.52Mn/m2014-09-09, From 2011-07-01
2011-06-30-$6.78Mn/m2013-09-18, From 2010-07-01
2010-06-30-$7.90Mn/m2013-09-18, From 2009-07-01
2009-06-30-$11.18Mn/m2013-09-18, From 2008-07-01
2008-06-30-$12.41Mn/m2013-09-18, From 2007-07-01
2007-06-30-$13.82Mn/m2013-09-18, From 2006-07-01
2006-06-30-$7.39Mn/m2013-09-18, From 2005-07-01
2005-06-30-$6.42Mn/m2013-09-18, From 2004-07-01
2004-06-30-$8.54Mn/m2013-09-18, From 2003-07-01
2003-06-30-$3.03Mn/m2013-09-18, From 2002-07-01
2002-06-30-$123.0Kn/a2013-09-18, From 2001-07-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Lite Strategy, Inc. (LITS)2025-06-30-$15.95Mn/m
Abbott Laboratories (ABT)2025-12-31$6.52B-51.3%
Bristol Myers Squibb Co (BMY)2025-12-31$7.05Bn/m
TherapeuticsMD, Inc. (TXMD)2025-12-31-$569.0Kn/m
Eli Lilly & Co (LLY)2025-12-31$20.64B+94.9%
Pfizer Inc (PFE)2025-12-31$7.77B-3.2%
Johnson & Johnson (JNJ)2025-12-28$26.80B+90.6%
Nature's Sunshine Products Inc (NATR)2025-12-31$20.45M+159.1%
Merck & Co., Inc. (MRK)2025-12-31$18.25B+6.6%

Compare LITS, ABT, BMY, TXMD side by side · Screen every company in Pharmaceutical Preparations ↗